Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 11, 2017
Mayne Pharma has announced the launch of Fabior® (tazarotene) Foam, 0.1% and Sorilux® (calcipotriene) Foam, 0.005% in the United States by Mayne Pharma’s Specialty Brands division.
read more
Mayne Pharma has entered into a long-term exclusive license and supply agreement with Mithra Pharmaceuticals SA (Mithra) for Myring®, an intravaginal hormonal contraceptive delivery device.
read more
Mayne Pharma has appointed Kimberly McClintock as executive vice president at Metrics Contract Services.
read more
Mayne Pharma Inc., has announced that the U.S. Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for doxycycline hyclate immediate release (IR) tablets (75 mg and 150 mg). Mayne Pharma has ...
read more
Mayne Pharma Group Limited, a publicly held company based in Melbourne, Australia, is pleased to announce that it has entered into a binding agreement to acquire Metrics, Inc., a privately-owned provider of contract development services to the ...
read more
Mayne Pharma is pleased to announce that it has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million.
read more
Mayne Pharma has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million. The portfolio consists of 37 approved products and 5 FDA filed products in attractive ...
read more
Wednesday, February 24, 2021
MaxiVAX and Minaris Regenerative Medicine GmbH have entered into a manufacturing agreement for MVX-ONCO-2.
read more
MaxCyte has appointed Brad Calvin, a 25-year veteran within the drug development and biotechnology industries, as Executive Vice President of Global Marketing.
read more
Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1.
read more
Monday, December 30, 2019
Mavidon is voluntarily recalling all lots of products manufactured at our facility including LemonPrep®, PediaPrep® and Wave Prep 4-ounce tubes and single use cups, Cardio Prep and Collodions, Collodion removers due to contamination with Burkholderia...
read more
Tuesday, November 19, 2024
Matica Biotechnology, Inc. announced the appointment of Min Park, MBA as Chief Commercial Officer.
read more
Tuesday, November 05, 2024
Matica Biotechnology announced the successful development of a high-resolution ion-exchange chromatography (IEX) method for analyzing the ratio of empty and full AAV8 (Adeno-Associated Virus 8) viral vector capsids. This significant advancement in ...
read more
Masy BioServices announced it has acquired Metrology Laboratories, Inc. (MLI) a calibration services provider located in Rockaway, NJ.
read more
MasterPharm is voluntarily recalling 1 lot of Finasteride Plus 1.25mg, capsules to the consumer level.
read more